Wednesday, February 10, 2010, 1:07PM AEST - The Australian Stockmarket closes in 2 hours and 58 minutes.
To create a watchlist or portfolio of shares, Register

Inovio Biomedical Corporation (INO)

8:00AM AEST: 1.18 USD  Down 0.05 (4.07%)  
 MORE ON INO 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 INOVIO BIOMED CORP (AMEX:INO) Delayed quote dataEdit
Last Trade:1.18 USD
Trade Time: 8:00AM AEST
Change:Down 0.05 (4.07%)
Prev Close:1.23
Open:1.23
Bid:N/A
Ask:N/A
1y Target Est:4.00
Day's Range:1.10 - 1.25
52wk Range:0.18 - 3.40
Volume:400,270
Avg Vol (3m):670,397
Market Cap:120.51M
P/E (ttm):N/A
EPS (ttm):-0.34
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add INO to Portfolio   Download Data

 HEADLINES 
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
Business Wire (Mon, Feb 8)
Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
Indie Research (Fri, Feb 5)
Inovio Biomedical to Present at BIO CEO & Investor Conference
Business Wire (Wed, Feb 3)
Inovio Unveils Skin Electroporation Technology for Delivering DNA Vaccines
Business Wire (Thu, Jan 28)
Inovio Biomedical to Present at Partnering and Vaccine Conferences
Business Wire (Wed, Jan 20)
Inovio Expands DNA Vaccine Intellectual Property License with University of Pennsylvania
Business Wire (Mon, Jan 11)
VGX Animal Health's Growth Hormone Releasing Hormone Shows Advantages Compared to Current Growth Hormone Therapies Used in Pigs
Business Wire (Fri, Jan 8)
Inovio Biomedical to Present at OneMedForum Investor Conference
Business Wire (Thu, Jan 7)
Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer
Business Wire (Wed, Jan 6)
Swine Flu Vaccine News Back From the Dead
Indie Research (Wed, Dec 30)
More Headlines for INO...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.29
EPS Est (in 2 years) (Dec-10) :-0.23
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices